These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 18046966

  • 1. Subgingival distribution of yeast and their antifungal susceptibility in immunocompetent subjects with and without dental devices.
    Jewtuchowicz VM, Brusca MI, Mujica MT, Gliosca LA, Finquelievich JL, Lovannitti CA, Rosa AC.
    Acta Odontol Latinoam; 2007; 20(1):17-22. PubMed ID: 18046966
    [Abstract] [Full Text] [Related]

  • 2. Phenotypic and genotypic identification of Candida dubliniensis from subgingival sites in immunocompetent subjects in Argentina.
    Jewtuchowicz VM, Mujica MT, Brusca MI, Sordelli N, Malzone MC, Pola SJ, Iovannitti CA, Rosa AC.
    Oral Microbiol Immunol; 2008 Dec; 23(6):505-9. PubMed ID: 18954358
    [Abstract] [Full Text] [Related]

  • 3. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.
    Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Meis JF, Gould IM, Fu W, Colombo AL, Rodriguez-Noriega E, Global Antifungal Surveillance Study.
    J Clin Microbiol; 2007 Jun; 45(6):1735-45. PubMed ID: 17442797
    [Abstract] [Full Text] [Related]

  • 4. Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole.
    Lee SC, Lo HJ, Fung CP, Lee N, See LC.
    J Microbiol Immunol Infect; 2009 Apr; 42(2):148-53. PubMed ID: 19597647
    [Abstract] [Full Text] [Related]

  • 5. Detection and antifungal susceptibility testing of oral Candida dubliniensis from human immunodeficiency virus-infected patients.
    Chunchanur SK, Nadgir SD, Halesh LH, Patil BS, Kausar Y, Chandrasekhar MR.
    Indian J Pathol Microbiol; 2009 Apr; 52(4):501-4. PubMed ID: 19805956
    [Abstract] [Full Text] [Related]

  • 6. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E, Espinel-Ingroff A, Szekely A, Hockey H, Troke P.
    Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Candida rugosa, an emerging fungal pathogen with resistance to azoles: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.
    Pfaller MA, Diekema DJ, Colombo AL, Kibbler C, Ng KP, Gibbs DL, Newell VA.
    J Clin Microbiol; 2006 Oct; 44(10):3578-82. PubMed ID: 17021085
    [Abstract] [Full Text] [Related]

  • 11. Broth medium for microdilution susceptibility tests of fluconazole and voriconazole.
    Barry A, Brown S, Traczewski M.
    Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):407-10. PubMed ID: 12072930
    [No Abstract] [Full Text] [Related]

  • 12. [Activity of voriconazole against yeasts isolated from blood culture determined by two methods].
    Cantón E, Pemán J, Bosch M, Viudes A, Gobernado M.
    Rev Esp Quimioter; 2005 Dec; 18(4):308-12. PubMed ID: 16446790
    [Abstract] [Full Text] [Related]

  • 13. Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre.
    Quindós G, Sánchez-Vargas LO, Villar-Vidal M, Eraso E, Alkorta M, Hernández-Almaraz JL.
    Int J Antimicrob Agents; 2008 Mar; 31(3):266-71. PubMed ID: 18054468
    [Abstract] [Full Text] [Related]

  • 14. In vitro activity of essential oils extracted from plants used as spices against fluconazole-resistant and fluconazole-susceptible Candida spp.
    Pozzatti P, Scheid LA, Spader TB, Atayde ML, Santurio JM, Alves SH.
    Can J Microbiol; 2008 Nov; 54(11):950-6. PubMed ID: 18997851
    [Abstract] [Full Text] [Related]

  • 15. [Yeast susceptibility isolated from blood cultures of patients at the National Cardiology Institute Ignacio Chávez].
    Hernández-Dueñas AM, Vázquez-Larios Mdel R, Soto-Nieto GI, Rivera-Martínez E.
    Rev Invest Clin; 2009 Nov; 61(4):294-9. PubMed ID: 19848306
    [Abstract] [Full Text] [Related]

  • 16. [Prevalence of vaginal candidiasis in pregnant women. Identification of yeasts and susceptibility to antifungal agents].
    García Heredia M, García SD, Copolillo EF, Cora Eliseth M, Barata AD, Vay CA, de Torres RA, Tiraboschi N, Famiglietti AM.
    Rev Argent Microbiol; 2006 Nov; 38(1):9-12. PubMed ID: 16784126
    [Abstract] [Full Text] [Related]

  • 17. [Fluconazole susceptibility of invasive Candida sp isolates as determined by three methods: Bogotá - Colombia].
    Torres D NA, Alvarez M CA, Rondón S MA.
    Rev Chilena Infectol; 2009 Apr; 26(2):135-43. PubMed ID: 19621144
    [Abstract] [Full Text] [Related]

  • 18. Effect of farnesol on Candida dubliniensis biofilm formation and fluconazole resistance.
    Jabra-Rizk MA, Shirtliff M, James C, Meiller T.
    FEMS Yeast Res; 2006 Nov; 6(7):1063-73. PubMed ID: 17042756
    [Abstract] [Full Text] [Related]

  • 19. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006.
    Yang YL, Wang AH, Wang CW, Cheng WT, Li SY, Lo HJ, TSARY Hospitals.
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.